ibrutinib April 12, 2017 ibrutinib Trade Name Imbruvica Orphan Indication Chronic Graft versus Host disease USA Market Approval USA USA Designation Date 2016-06-23 00:00:00 Sponsor Pharmacyclics, LLC;995 East Arques Avenue;Sunnyvale, California, 94085
